Current Issue

Application of Quality Risk Management to Process Validation

Robert Dream, Managing Director, HDR Company LLC

A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization

Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...

Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...

Ping Wang, Director, Johnson & Johnson

Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics

Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...

Amsphere A3

JSR Life Sciences



Headline News

Lilly highlights retatrutide, Taltz and Zepbound data across rheumatologic diseases and obesity


Lilly and Hims & Hers expand access to Zepbound and Foundayo


Moderna advances Bundibugyo ebolavirus vaccine toward Phase II/III study


Read All Headlines

Upcoming Webinars

View All Upcoming Webinars

Past Webinars

Points to consider when defining a microbial control strategy for individualized ATMPs

Presented by Friedrich von Wintzingerode, PhD, QC Lead iNeST Project (individualized Neoantigen Specific Therapy)
05th April 2023


Is India Anywhere Closer to Implementing Continuous Bioprocessing

Presented by Narasimha Rao Nedunuri, Managing Director of CLONZ and José Castillo, PhD, CTo and co-founder of Univercells
16th August 2018


Subvisible Particles Matter, Developments in Regulations and Low Volume Methods

Presented by Dr Satish K Singh, Lonza
26th July 2018


View All Past Webinars

Featured Companies

 

View All Companies

© 2026 biopharma-asia.com. All rights reserved. Privacy Policy

Biopharma Asia